Table 1.
PAI | APS-II | APS-I with PAI* | |
---|---|---|---|
Patients, n | 305 | 372 | 34 |
Frequency of females (%) | 50.3 | 72.0 | 41.2 |
Age at diagnosis (years) | 33.1 ± 15.4 | 36.6 ± 14.8 | 15.7 ± 9.6 |
Time between diagnosis and first sample (years) | 11.5 ± 13.5 | 11.2 ± 12.7 | 15.0 ± 15.3 |
21OH-Abs index | 577± 356 | 620 ± 319 | 317 ± 228 |
Positivity for 21OH-Abs (%) | 88.2 | 93.8 | 85.3 |
Males | 89.4% | 93.2% | |
Females | 87.6% | 93.6% |
APS, autoimmune polyendocrine syndrome; PAI, primary adrenocortical failure (isolated).